|drug3081||Serum tube collection Wiki||1.00|
|drug482||Blood sample Wiki||0.30|
There is one clinical trial.
During the Covid-19 pandemic, non-operative management for acute appendicitis (AA) was implemented in the UK. The aim of this study was to determine the efficacy and outcomes of conservative versus surgical management of AA during the pandemic.
Description: Death secondary to acute appendicitisMeasure: Mortality Time: within 90 days of a patient's initial presentation
Description: failure of conservative management and need to undergo surgeryMeasure: Failure of primary proposed treatment Time: within 90 days of a patient's initial presentation
Description: length of stay in hospital from admission date till discharge date or deathMeasure: length of stay Time: within 90 days of a patient's initial presentation
Description: Re-attendance to hospital after patient's discharge whether planned or unplannedMeasure: Re-attendance Time: within 90 days of a patient's initial presentation
Description: imaging modality obtained and findings to confirm the diagnosis of acute appendicitisMeasure: Imaging Time: within 90 days of a patient's initial presentation
Description: Intra-operative findings of pus or free fluid during appendicectomyMeasure: Intra-operative findings during surgery Time: within 90 days of a patient's initial presentation
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports